Multi-drug therapy in bacilliferous leprosy--two years experience.
The data of thirty patients who completed two years of multi-drug therapy (MDT) is analysed in regard to clinical improvement, occurrence of reactions, bacteriological response and compliance to therapy.
D000328:Adult; D002991:Clofazimine / Q000009:adverse effects / Q000627:therapeutic use*; D003622:Dapsone / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D010349:Patient Compliance; D012293:Rifampin / Q000627:therapeutic use*; D012646:Self Administration
D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin